Working… Menu

Safety and Efficacy Evaluation of ET-01 Transplantation in Subjects With Transfusion Dependent β-Thalassaemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04390971
Recruitment Status : Recruiting
First Posted : May 18, 2020
Last Update Posted : February 23, 2021
EdiGene Inc.
Information provided by (Responsible Party):
Jun Shi, Institute of Hematology & Blood Diseases Hospital

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 31, 2021
Estimated Study Completion Date : October 15, 2023